Please use this identifier to cite or link to this item:
https://dipositint.ub.edu/dspace/handle/2445/149227
Title: | Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis |
Author: | Matas, Jessica Llorenç, Victor Fonollosa, Alex Esquinas López, Cristina Díaz Valle, David Berasategui, Barbara Mesquida, Marina Artaraz, Joseba Ríos, José Adán Civera, Alfredo |
Keywords: | Uveïtis Edema Uveitis Edema |
Issue Date: | 24-Jan-2019 |
Publisher: | Public Library of Science (PLoS) |
Abstract: | Aims: We aimed to investigate predictive factors for visual and anatomic outcomes in patients with macular edema secondary to non-infectious uveitis. Material and methods: We conducted a multicenter, prospective, observational, 12-month follow-up study. Participants included in the study were adults with non-infectious uveitic macular edema (UME), defined as central subfoveal thickness (CST) of > 300 mu m as measured by spectral domain optical coherence tomography (SD-OCT) and fluid in the macula. Demographic, clinical and tomographic data was recorded at baseline, 1, 3, 6 and 12 months. Foveal-centered SD-OCT exploration was set as the gold-standard determination of UME using a standard Macular Cube 512x128 A-scan, within a 6 x 6 mm(2) area, and the Enhanced High Definition Single-Line Raster. To assess favorable prognosis, the main outcomes analyzed were the best-corrected visual acuity (BCVA) and the CST. Favorable prognosis was defined as sustained improvement of BCVA (2 lines of gain of the Snellen scale) and CST (decrease of 20% of the initial value or < 300 mu m) within a 12 month period. Results: Fifty-six eyes were analyzed. The number of eyes with sustained improvement in the CST was 48 (86.2%), against 23 (41.1%) eyes with sustained improvement in BCVA. Favorable prognosis, as defined above, was observed in 18 (32.1%) eyes. UME prognosis was negatively correlated with baseline foveal thickening, alteration in the vitreo-macular interface and cystoid macular edema. In contrast, bilaterally, systemic disease and the presence of anterior chamber cells were predictive of favorable prognosis. Conclusion: Available treatment modalities in UME may avoid chronic UME and improve anatomic outcome. However, the proportion of functional amelioration observed during 12 months of follow-up is lower. Thicker CST, alteration in the vitreo-macular interface and cystoid macular edema may denote less favorable prognosis. Conversely, bilaterally, systemic disease and anterior chamber cells may be associated with favorable prognosis in UME. |
Note: | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0210799 |
It is part of: | PLoS One, 2019, vol. 14, num. 1, p. e0210799 |
URI: | http://hdl.handle.net/2445/149227 |
Related resource: | https://doi.org/10.1371/journal.pone.0210799 |
ISSN: | 1932-6203 |
Appears in Collections: | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
687866.pdf | 496.98 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License